Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 11:59 am Purchase | 2025-06-30 | 13G | Tenaya Therapeutics, Inc. TNYA | Woodline Partners LP | 9,000,000 4.990% | 3,083,833 (+52.13%) | Filing History |
| 2025-08-14 11:58 am Purchase | 2025-06-30 | 13G | Sagimet Biosciences Inc. SGMT | Woodline Partners LP | 2,552,536 8.300% | 2,552,536 (New Position) | Filing History |
| 2025-08-14 11:56 am Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Woodline Partners LP | 6,029,906 5.600% | 6,029,906 (New Position) | Filing History |
| 2025-08-14 11:55 am Purchase | 2025-06-30 | 13G | AIRO Group Holdings, Inc. Common Stock AIRO | Woodline Partners LP | 1,952,611 7.200% | 1,952,611 (New Position) | Filing History |
| 2025-08-14 11:54 am Purchase | 2025-06-30 | 13G | Aligos Therapeutics, Inc. ALGS | Woodline Partners LP | 518,300 9.800% | 202,917 (+64.34%) | Filing History |
| 2025-05-15 09:33 am Purchase | 2025-03-31 | 13G | Aligos Therapeutics, Inc. ALGS | Woodline Partners LP | 315,383 5.200% | 315,383 (New Position) | Filing History |
| 2025-05-15 09:32 am Purchase | 2025-03-31 | 13G | Tenaya Therapeutics, Inc. TNYA | Woodline Partners LP | 5,916,167 6.800% | 5,916,167 (New Position) | Filing History |
| 2025-05-15 09:30 am Purchase | 2025-03-31 | 13G | Outset Medical, Inc. OM | Woodline Partners LP | 1,325,784 7.500% | 1,325,784 (New Position) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 2,114,056 2.400% | -2,226,284 (-51.29%) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | Protara Therapeutics, Inc. TARA | Woodline Partners LP | 1,331,258 3.900% | -245,309 (-15.56%) | Filing History |
| 2025-02-14 4:05 pm Sale | 2024-12-31 | 13G | Guardian Pharmacy Services, Inc. GRDN | Woodline Partners LP | 415,120 4.500% | -153,011 (-26.93%) | Filing History |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | Guardian Pharmacy Services, Inc. GRDN | Woodline Partners LP | 568,131 6.200% | 568,131 (New Position) | Filing History |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | Protara Therapeutics, Inc. TARA | Woodline Partners LP | 1,576,567 7.400% | 1,576,567 (New Position) | Filing History |
| 2024-11-14 1:00 pm Purchase | 2024-09-30 | 13G | Zevra Therapeutics, Inc. ZVRA | Woodline Partners LP | 4,048,653 7.700% | 4,048,653 (New Position) | Filing History |
| 2024-02-12 4:38 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Woodline Partners LP | 1,140,632 2.200% | 1,140,632 (New Position) | Filing History |
| 2024-02-12 4:33 pm Sale | 2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Woodline Partners LP | 12,500 0.400% | -27,500 (-68.75%) | Filing History |
| 2024-02-12 4:32 pm Sale | 2023-12-31 | 13G | OPY Acquisition Corp. I OHAA | Woodline Partners LP | 0 0.000% | -200,000 (Position Closed) | Filing History |
| 2023-02-10 4:10 pm Sale | 2022-12-31 | 13G | Ascendant Digital Acquisition Corp. III ACDI | Woodline Partners LP | 1,286,000 4.300% | -626,500 (-32.76%) | Filing History |
| 2023-02-10 4:10 pm Purchase | 2022-12-31 | 13G | OPY Acquisition Corp. I OHAA | Woodline Partners LP | 200,000 8.100% | 200,000 (New Position) | Filing History |